Eugene Wyatt

1.3k total citations
16 papers, 968 citations indexed

About

Eugene Wyatt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Eugene Wyatt has authored 16 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Surgery. Recurrent topics in Eugene Wyatt's work include Muscle Physiology and Disorders (7 papers), CRISPR and Genetic Engineering (3 papers) and Mitochondrial Function and Pathology (3 papers). Eugene Wyatt is often cited by papers focused on Muscle Physiology and Disorders (7 papers), CRISPR and Genetic Engineering (3 papers) and Mitochondrial Function and Pathology (3 papers). Eugene Wyatt collaborates with scholars based in United States, Australia and Canada. Eugene Wyatt's co-authors include Cynthia Shannon Weickert, Maree J. Webster, Rongxue Wu, Hossein Ardehali, Elizabeth M. McNally, Mohsen Ghanefar, Markku Laakso, Patrick Page, Lisa Dellefave‐Castillo and Gary E. Schiltz and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Eugene Wyatt

16 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugene Wyatt United States	13	422	301	156	120	105	16	968
Marcin Piechota Poland	22	550 1.3×	445 1.5×	129 0.8×	83 0.7×	90 0.9×	61	1.4k
Parizad M. Bilimoria United States	12	554 1.3×	299 1.0×	74 0.5×	69 0.6×	130 1.2×	13	1.0k
Stefano Garofalo Italy	18	260 0.6×	179 0.6×	202 1.3×	98 0.8×	91 0.9×	33	1.0k
Phillip D. Rivera United States	14	351 0.8×	297 1.0×	113 0.7×	72 0.6×	375 3.6×	18	1.0k
N. Zečević Serbia	12	271 0.6×	236 0.8×	72 0.5×	116 1.0×	262 2.5×	31	870
Sabina Luchetti Netherlands	17	301 0.7×	278 0.9×	107 0.7×	61 0.5×	108 1.0×	24	1.2k
Tomohiro Ohgomori Japan	14	270 0.6×	302 1.0×	115 0.7×	37 0.3×	128 1.2×	28	1.1k
Bing Lang China	20	621 1.5×	354 1.2×	99 0.6×	100 0.8×	133 1.3×	65	1.1k
Michał Ślęzak Poland	13	274 0.6×	356 1.2×	49 0.3×	81 0.7×	155 1.5×	18	840
María Santos‐Galindo Spain	17	436 1.0×	326 1.1×	76 0.5×	45 0.4×	145 1.4×	21	1.2k

Countries citing papers authored by Eugene Wyatt

Since Specialization

Citations

This map shows the geographic impact of Eugene Wyatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Wyatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Wyatt more than expected).

Fields of papers citing papers by Eugene Wyatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Wyatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Wyatt. The network helps show where Eugene Wyatt may publish in the future.

Co-authorship network of co-authors of Eugene Wyatt

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Wyatt. A scholar is included among the top collaborators of Eugene Wyatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Wyatt. Eugene Wyatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

H., Ki, et al.. (2022). JUN Regulation of Injury-Induced Enhancers in Schwann Cells. Journal of Neuroscience. 42(34). 6506–6517. 15 indexed citations

Zhai, Lijie, April Bell, Erik Ladomersky, et al.. (2020). Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies. Frontiers in Immunology. 11. 1185–1185. 155 indexed citations

Marcheva, Biliana, Mark Perelis, Benjamin J. Weidemann, et al.. (2020). A role for alternative splicing in circadian control of exocytosis and glucose homeostasis. Genes & Development. 34(15-16). 1089–1105. 20 indexed citations

Barefield, David Y., Andy H. Vo, Anthony Gacita, et al.. (2019). Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight. 4(6). 25 indexed citations

Demonbreun, Alexis R., Eugene Wyatt, Patrick Page, et al.. (2019). A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping. Disease Models & Mechanisms. 13(2). 18 indexed citations

Wyatt, Eugene, Alexis R. Demonbreun, Megan J. Puckelwartz, et al.. (2018). Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight. 3(9). 14 indexed citations

Wu, Rongxue, Kirsten M. Smeele, Eugene Wyatt, et al.. (2017). ISCHEMIA-REPERFUSION INJURY. 12 indexed citations

McNally, Elizabeth M. & Eugene Wyatt. (2017). Mutation-Based Therapy for Duchenne Muscular Dystrophy. Circulation. 136(11). 979–981. 12 indexed citations

Page, Patrick, et al.. (2016). Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease. Skeletal Muscle. 6(1). 32–32. 39 indexed citations

10.

Gao, Quan Q., Eugene Wyatt, Jeffrey A. Goldstein, et al.. (2015). Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. Journal of Clinical Investigation. 125(11). 4186–4195. 29 indexed citations

11.

Wyatt, Eugene, H. Lee Sweeney, & Elizabeth M. McNally. (2014). Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014. Journal of Neuromuscular Diseases. 1(2). 197–206. 1 indexed citations

12.

Wu, Rongxue, Eugene Wyatt, Mohsen Ghanefar, et al.. (2012). Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Molecular Medicine. 4(7). 633–646. 71 indexed citations

13.

Weickert, Cynthia Shannon, et al.. (2011). Decreased BDNF, trkB-TK+ and GAD₆₇ mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. Journal of Psychiatry and Neuroscience. 36(3). 195–203. 294 indexed citations

14.

Wyatt, Eugene, Rongxue Wu, Wael M. Rabeh, et al.. (2010). Regulation and Cytoprotective Role of Hexokinase III. PLoS ONE. 5(11). e13823–e13823. 53 indexed citations

15.

Wu, Rongxue, Kirsten M. Smeele, Eugene Wyatt, et al.. (2010). Reduction in Hexokinase II Levels Results in Decreased Cardiac Function and Altered Remodeling After Ischemia/Reperfusion Injury. Circulation Research. 108(1). 60–69. 72 indexed citations

16.

Weickert, Cynthia Shannon, et al.. (2009). Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. Journal of Psychiatric Research. 43(11). 970–977. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact